Autism Congress 2026

Introduction: Contemporary autism research has largely emphasized genetic, prenatal, and maternal health factors, while comparatively limited attention has been given to the infant’s immediate physical microenvironment. This study examines the association between stagnant air in modern solid-walled cribs and the localized loss of neural progenitor cells during critical periods of brain development.

Methods: Animal models were used in conjunction with environmental monitoring of standard infant sleep furniture (130 × 70 cm). CO2 concentrations were measured within the 10 cm respiratory zone. Blood pH was monitored to assess the development of respiratory acidosis. Comparative analyses were performed between stationary “bucket-style” cribs and traditional swinging cradles (beshiks).

Results: The data indicated that within 60 minutes of sleep in a poorly ventilated “bucket” crib, CO2 concentrations exceeded 70,000 ppm (7%). This hypercapnic environment was associated with a decline in blood pH below 7.35, reaching severely acidotic levels of 7.0. In animal models, this acute acidosis selectively induced apoptosis in metabolically active neural progenitor cells. In contrast, the horizontal air movement characteristic of a swinging beshik or floor-level cross-ventilation maintained CO2 concentrations near ambient levels and preserved physiological blood pH at approximately 7.4.

Conclusion: These findings suggest that autism may, in part, involve structural brain injury associated with preventable environmental acidosis. We propose the addition of a “25th Point” to public health standards: mandatory horizontal air exchange at floor level. Redesigning infant sleep environments to eliminate localized CO2 accumulation may represent a non-invasive, high-impact strategy for the primary prevention of neurodevelopmental and metabolic disorders.

Dr. Mavis Boakye-Yiadom is the Head of Department for the Microbiology Department of CPMR, Ghana. She is a Medical Herbalist, a Natural Product Chemist, a Clinical Pharmacologist, and a Clinical trialist with expertise in clinical consultation and trials, natural product research, and health policy development. She holds a BSc. Herbal Medicine from Kwame Nkrumah University of Science and Technology (KNUST), in Kumasi - Ghana, a Master of Philosophy in Chinese Materia Medica (Natural Product Chemistry) from the Tianjin University of Traditional Chinese Medicine, PR China, a Doctor of Philosophy in Clinical Pharmacology at KNUST, Kumasi – Ghana and an Master of Science in Clinical Trials, at University of Ghana.